Survival of Motor Neuron 1 (SMN1) Mutation Analysis
The SMN1 (Survival of motor neuron 1) gene is located in the long (q) arm of chromosome 5 at position 13.2 and encodes the SMN protein. SMN protein is mainly found in motor neurons in the brainstem and spinal cord. In neurons, the SMN protein acts as a catalyst in the assembly of small ribonuceoproteins (snRNP) and plays an important role in splicing messenger RNA (mRNA). The SMN complex is also important for the development of dendrites and axons are required for the transmission of impulses between neurons and from neurons to muscles. Two nearly identical SMN genes are present on chromosome 5q13: SMN1 and SMN2. The difference between these two genes is a single transition (840C>T) in SMN2 that leads to far fewer fully functioning transcripts (10-20%) comparted to the SMN1 gene. Mutations in SMN1 are associated with spinal muscular atrophy (SMA).
SMA is transmitted in an autosomal recessive manner with each parent contributing one mutated SMN1 gene. In all types of SMA, the SMN2 gene continues to make lesser amounts of functioning protein, and patients can have from 1 to 4 copies of this gene. The clinical severity of SMA is at least partially related to how many copies of the SMN2 gene are present, although other factors than SMN2 copy number also seem to be involved.
Spinal muscular atrophy (SMA) is characterized by motor neuron degeneration leading to muscular atrophy with progressive paralysis. Due to mutations in SMN1, insufficient SMN protein is available to process pre-mRNA and leads to a lack of mature mRNA, and subsequently the proteins needed for normal cell functioning. Individuals with SMA experience significant hypotonia, proximal muscle weakness, and muscular atrophy.
SMA is classified based on the age of onset and severity of clinical symptoms. The most severe form is SMA type 0 in which the onset occurs prenatally. Individuals with this condition experience severe neonatal hypotonia, weakness, early respiratory failure, and facial diplegia. Typically, babies with SMA type 0 live less than 6 months.
SMA type I, also called Werdnig-Hoffman disease, is associated with severe, generalized muscle weakness and loss of muscle tone at birth or within the first six months of life. Respiratory failure and subsequent death usually occur by the age of two. SMA type I accounts for 60% to 70% of the cases.
Children with SMA type II, or Dubowitz disease, are diagnosed between 6 and 18 months of age They may be able to sit but is unable to stand or walk without assistance. Scoliosis and problems with swallowing and coughing are common. About 70% of individuals with SMA type II survive to the age of 25.
SMA type III, also known as Kugelberg-Welander disease, is characterized by proximal muscle weakness that manifests after 18 months of age. SMA type III may also be subdivided into types IIIa (with onset before age 3) and IIIb (with onset after age 3). Individuals with SMA type III learn to walk independently but eventually experience frequent falls and difficulty with stairs; disease progression may also result in the need for a wheelchair in adulthood.
SMA type IV is less severe and individuals with SMA type IV have a normal life expectancy with mild muscle weakness and no respiratory system involvement.
- Diagnostic confirmation and management of Spinal Muscular Atrophy
- Carrier testing for Spinal Muscular Atrophy gene mutation
- Prenatal diagnosis for Spinal Muscular Atrophy
Negative for mutations analyzed (no mutation detected)
Whole Blood (EDTA), ACD (Yellow) or Amniotic Fluid.
Stability
- Ambient: 5-7 days
- Refrigerated: 7-14 days
- Neurotherapeutics. 2015 Apr;12(2):290-302. [PMID: 25413156]
- Curr Opin Neurol. 2010 Oct;23(5):450-8. [PMID: 20733483]
- J Child Neurol. 2007 Aug;22(8):952-6. [PMID: 17761649]
- J Obstet Gynecol Neonatal Nurs. 2004 Jan-Feb;33(1):12-20. [PMID: 14971549]
- Expert Rev Mol Diagn. 2004 Jan;4(1):15-29. [PMID: 14711346]
- Eur J Med Genet. 2018 Nov;61(11):685-698. [PMID: 29313812]
- Dis Model Mech. 2017 Aug 1;10(8):943-954. [PMID: 28768735]
- Curr Mol Med. 2009 Sep;9(7):851-62. [PMID: 19860664]
- Hum Mutat. 2000;15(3):228-37. [PMID: 10679938]
- Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/gene/SMN1#
- GeneReviews® [Internet]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1352/